Cargando…
Involvement of Endocytosis in the Transdermal Penetration Mechanism of Ketoprofen Nanoparticles
We previously designed a novel transdermal formulation containing ketoprofen solid nanoparticles (KET-NPs formulation), and showed that the skin penetration from the KET-NPs formulation was higher than that of a transdermal formulation containing ketoprofen microparticles (KET-MPs formulation). Howe...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073289/ https://www.ncbi.nlm.nih.gov/pubmed/30041452 http://dx.doi.org/10.3390/ijms19072138 |
_version_ | 1783344157323952128 |
---|---|
author | Nagai, Noriaki Ogata, Fumihiko Ishii, Miyu Fukuoka, Yuya Otake, Hiroko Nakazawa, Yosuke Kawasaki, Naohito |
author_facet | Nagai, Noriaki Ogata, Fumihiko Ishii, Miyu Fukuoka, Yuya Otake, Hiroko Nakazawa, Yosuke Kawasaki, Naohito |
author_sort | Nagai, Noriaki |
collection | PubMed |
description | We previously designed a novel transdermal formulation containing ketoprofen solid nanoparticles (KET-NPs formulation), and showed that the skin penetration from the KET-NPs formulation was higher than that of a transdermal formulation containing ketoprofen microparticles (KET-MPs formulation). However, the precise mechanism for the skin penetration from the KET-NPs formulation was not clear. In this study we investigated whether energy-dependent endocytosis relates to the transdermal delivery from a 1.5% KET-NPs formulation. Transdermal formulations were prepared by a bead mill method using additives including methylcellulose and carbopol 934. The mean particle size of the ketoprofen nanoparticles was 98.3 nm. Four inhibitors of endocytosis dissolved in 0.5% DMSO (54 μM nystatin, a caveolae-mediated endocytosis inhibitor; 40 μM dynasore, a clathrin-mediated endocytosis inhibitor; 2 μM rottlerin, a macropinocytosis inhibitor; 10 μM cytochalasin D, a phagocytosis inhibitor) were used in this study. In the transdermal penetration study using a Franz diffusion cell, skin penetration through rat skin treated with cytochalasin D was similar to the control (DMSO) group. In contrast to the results for cytochalasin D, skin penetration from the KET-NPs formulation was significantly decreased by treatment with nystatin, dynasore or rottlerin with penetrated ketoprofen concentration-time curves (AUC) values 65%, 69% and 73% of control, respectively. Furthermore, multi-treatment with all three inhibitors (nystatin, dynasore and rottlerin) strongly suppressed the skin penetration from the KET-NPs formulation with an AUC value 13.4% that of the control. In conclusion, we found that caveolae-mediated endocytosis, clathrin-mediated endocytosis and macropinocytosis are all related to the skin penetration from the KET-NPs formulation. These findings provide significant information for the design of nanomedicines in transdermal formulations. |
format | Online Article Text |
id | pubmed-6073289 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-60732892018-08-13 Involvement of Endocytosis in the Transdermal Penetration Mechanism of Ketoprofen Nanoparticles Nagai, Noriaki Ogata, Fumihiko Ishii, Miyu Fukuoka, Yuya Otake, Hiroko Nakazawa, Yosuke Kawasaki, Naohito Int J Mol Sci Article We previously designed a novel transdermal formulation containing ketoprofen solid nanoparticles (KET-NPs formulation), and showed that the skin penetration from the KET-NPs formulation was higher than that of a transdermal formulation containing ketoprofen microparticles (KET-MPs formulation). However, the precise mechanism for the skin penetration from the KET-NPs formulation was not clear. In this study we investigated whether energy-dependent endocytosis relates to the transdermal delivery from a 1.5% KET-NPs formulation. Transdermal formulations were prepared by a bead mill method using additives including methylcellulose and carbopol 934. The mean particle size of the ketoprofen nanoparticles was 98.3 nm. Four inhibitors of endocytosis dissolved in 0.5% DMSO (54 μM nystatin, a caveolae-mediated endocytosis inhibitor; 40 μM dynasore, a clathrin-mediated endocytosis inhibitor; 2 μM rottlerin, a macropinocytosis inhibitor; 10 μM cytochalasin D, a phagocytosis inhibitor) were used in this study. In the transdermal penetration study using a Franz diffusion cell, skin penetration through rat skin treated with cytochalasin D was similar to the control (DMSO) group. In contrast to the results for cytochalasin D, skin penetration from the KET-NPs formulation was significantly decreased by treatment with nystatin, dynasore or rottlerin with penetrated ketoprofen concentration-time curves (AUC) values 65%, 69% and 73% of control, respectively. Furthermore, multi-treatment with all three inhibitors (nystatin, dynasore and rottlerin) strongly suppressed the skin penetration from the KET-NPs formulation with an AUC value 13.4% that of the control. In conclusion, we found that caveolae-mediated endocytosis, clathrin-mediated endocytosis and macropinocytosis are all related to the skin penetration from the KET-NPs formulation. These findings provide significant information for the design of nanomedicines in transdermal formulations. MDPI 2018-07-23 /pmc/articles/PMC6073289/ /pubmed/30041452 http://dx.doi.org/10.3390/ijms19072138 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Nagai, Noriaki Ogata, Fumihiko Ishii, Miyu Fukuoka, Yuya Otake, Hiroko Nakazawa, Yosuke Kawasaki, Naohito Involvement of Endocytosis in the Transdermal Penetration Mechanism of Ketoprofen Nanoparticles |
title | Involvement of Endocytosis in the Transdermal Penetration Mechanism of Ketoprofen Nanoparticles |
title_full | Involvement of Endocytosis in the Transdermal Penetration Mechanism of Ketoprofen Nanoparticles |
title_fullStr | Involvement of Endocytosis in the Transdermal Penetration Mechanism of Ketoprofen Nanoparticles |
title_full_unstemmed | Involvement of Endocytosis in the Transdermal Penetration Mechanism of Ketoprofen Nanoparticles |
title_short | Involvement of Endocytosis in the Transdermal Penetration Mechanism of Ketoprofen Nanoparticles |
title_sort | involvement of endocytosis in the transdermal penetration mechanism of ketoprofen nanoparticles |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073289/ https://www.ncbi.nlm.nih.gov/pubmed/30041452 http://dx.doi.org/10.3390/ijms19072138 |
work_keys_str_mv | AT nagainoriaki involvementofendocytosisinthetransdermalpenetrationmechanismofketoprofennanoparticles AT ogatafumihiko involvementofendocytosisinthetransdermalpenetrationmechanismofketoprofennanoparticles AT ishiimiyu involvementofendocytosisinthetransdermalpenetrationmechanismofketoprofennanoparticles AT fukuokayuya involvementofendocytosisinthetransdermalpenetrationmechanismofketoprofennanoparticles AT otakehiroko involvementofendocytosisinthetransdermalpenetrationmechanismofketoprofennanoparticles AT nakazawayosuke involvementofendocytosisinthetransdermalpenetrationmechanismofketoprofennanoparticles AT kawasakinaohito involvementofendocytosisinthetransdermalpenetrationmechanismofketoprofennanoparticles |